The found 3-hydroxy-methyl-amyl coenzyme A (-) reductase inhibitor can inhibit the biosynthesis of cholesterol. A single-reductase inhibitor, or a combination of cholic acid, had a more pronounced effect on hypercholesterolemia. -reductase inhibitor is a new kind of promising lipid-lowering drug. Statins are most likely to be methylated coenzyme A (-) reductase inhibitors, with lovastatin, Pravastatin, Simvastatin and simvastatin available in the existing preparations for treatment.
Inhibitory Agents Of Hydroxy-dimethyl Valerate-coenzyme A (-) Reductase
- Jul 12, 2017 -